十大电竞官方买外围

Other Plans and Options
  • 0.14 % Nav, as on 09-09-2022

  • Previous Nav

  • Net Change on 09-09-2022

  • 十大电竞(广州)最新版登录正规 Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that before expenses, closely correspond to the total returns of securities as represented by Nifty Healthcare TRI, subject to tracking errors. However, the performance of scheme may differ from that of the underlying index due to tracking error.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India ETF Nifty 50 BeES Dec 28, 2001 4.05 18.70 13.72 0.05 9,665.75
Kotak Nifty Bank ETF Dec 04, 2014 10.79 13.32 10.52 0.18 7,054.98
ICICI Prudential Nifty 50 ETF Mar 20, 2013 4.05 18.69 13.68 0.05 3,966.56
Nippon India ETF Nifty Next 50 Junior BeES Feb 21, 2003 4.22 19.85 10.08 0.17 2,993.41
Kotak Nifty 50 ETF Feb 02, 2010 3.95 18.56 13.59 0.12 1,810.99

Fund Holdings as on 31-August-2022

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Dr. Reddys Laboratories Limited

  • Divi's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Laurus Labs Limited

  • Lupin Limited

  • Aurobindo Pharma Limited

  • Torrent Pharmaceuticals Limited

  • Alkem Laboratories Limited

  • Biocon Limited

  • IPCA Laboratories Limited

  • Abbott India Limited

  • Zydus Lifesciences Limited

  • Dr. Lal Path Labs Limited

  • Syngene International Limited

  • Pfizer Limited

  • Glenmark Pharmaceuticals Limited

  • Granules India Limited

  • METROPOLIS HEALTHCARE LIMITED

  • Net Receivables / (Payables)

  • Clearing Corporation of India Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Aditya Birla Sun Life Nifty Healthcare ETF

Scheme Analysis

Aditya Birla Sun Life Nifty Healthcare ETF is a ETFs - Index fund and belongs to Aditya Birla Sun Life Mutual Fund . It was launched on 21-Oct-2021 and currently has an AUM of ₹26.68 crore. Aditya Birla Sun Life Nifty Healthcare ETF is benchmarked against Nifty Healthcare Index - TRI as primary index.

The NAV of Aditya Birla Sun Life Nifty Healthcare ETF ended up ₹0.01 (0.14%) yesterday to ₹8.0792 .

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Aditya Birla Sun Life Nifty Healthcare ETF is managed by Lovelish Solanki and Pranav Gupta.

Fund House Contact

One India Bulls Centre , Tower 1, 17th Floor, Jupiter Mill Compound, 841, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111
英雄联盟竞猜赛事在线永久 fifa电竞(长春)手游外围1.4.10 gtv电竞比赛数据 大圣电竞数据APP v2.3 esg电竞比分详情 lpl电竞比赛排名官网